Clinical Trials Browser

Phase 2/3 × alovudine × Clear all

NCT00894101 2018-07-20

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

Phase 2/3 Withdrawn

Head and Neck Neoplasms